IL147887A0 - Use of chemical chelators as reversal agents for drug-induced neuromuscular block - Google Patents

Use of chemical chelators as reversal agents for drug-induced neuromuscular block

Info

Publication number
IL147887A0
IL147887A0 IL14788700A IL14788700A IL147887A0 IL 147887 A0 IL147887 A0 IL 147887A0 IL 14788700 A IL14788700 A IL 14788700A IL 14788700 A IL14788700 A IL 14788700A IL 147887 A0 IL147887 A0 IL 147887A0
Authority
IL
Israel
Prior art keywords
drug
reversal agents
neuromuscular block
induced neuromuscular
chemical chelators
Prior art date
Application number
IL14788700A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL147887A0 publication Critical patent/IL147887A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL14788700A 1999-08-13 2000-08-07 Use of chemical chelators as reversal agents for drug-induced neuromuscular block IL147887A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99306411 1999-08-13
PCT/EP2000/007694 WO2001012202A2 (fr) 1999-08-13 2000-08-07 Utilisation d'agents chimiques chelatants comme agents de neutralisation du blocage neuromusculaire provoque par des medicaments

Publications (1)

Publication Number Publication Date
IL147887A0 true IL147887A0 (en) 2002-08-14

Family

ID=8241574

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14788700A IL147887A0 (en) 1999-08-13 2000-08-07 Use of chemical chelators as reversal agents for drug-induced neuromuscular block

Country Status (11)

Country Link
US (3) US7265099B1 (fr)
EP (1) EP1210090B1 (fr)
JP (1) JP4782334B2 (fr)
CN (1) CN1241576C (fr)
AR (1) AR025103A1 (fr)
AU (1) AU780416B2 (fr)
BR (1) BR0013126A (fr)
CA (1) CA2380920C (fr)
IL (1) IL147887A0 (fr)
MX (1) MXPA02001545A (fr)
WO (1) WO2001012202A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
WO2003077906A1 (fr) * 2002-03-18 2003-09-25 Nihon University Derives d'etheramine cyclique servant de medicaments pour les tumeurs malignes
WO2008107887A2 (fr) * 2007-03-08 2008-09-12 Chemagis Ltd. Procédé de séparation de sels (1r,1'r)-atracurium
WO2008117271A1 (fr) * 2007-03-26 2008-10-02 Chemagis Ltd. Procédé de séparation de sels de (1r, 1'r)-atracurium
US8357807B2 (en) * 2007-05-01 2013-01-22 Chemagis Ltd. Isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates
WO2008132748A1 (fr) * 2007-05-01 2008-11-06 Chemagis Ltd. Procédé de fabrication de composés de cisatracurium et intermédiaires associés
US8357805B2 (en) * 2007-06-18 2013-01-22 Chemagis Ltd. (1R,1′R)-atracurium salts separation process
CA2692636A1 (fr) * 2007-07-09 2009-01-15 Chemagis Ltd. Procede de fabrication de cisatracurium et d'intermediaires associes
CA2702535A1 (fr) * 2007-10-29 2009-05-07 Chemagis Ltd. Nouveaux sels de r,r'-atracurium
BRPI0907656A2 (pt) * 2008-05-01 2019-08-27 Chemagis Ltd composto para testar a pureza de cisatracúrio, método para testar a pureza de uma amostra de besilato de cisatracúrio, uso de um composto para testar a pureza de cisatracúrio e processo para preparar compostos para testar a pureza de cisatracúrio
KR20110067130A (ko) 2008-09-22 2011-06-21 아카리오스 비.브이. 약제로서 유용한 카르복시에틸화 사이클로덱스트린 폴리설페이트
US11013750B2 (en) 2017-01-20 2021-05-25 Aurin Biotech Inc. Methods for treating and preventing nociceptive pain
US20210292479A1 (en) 2018-08-02 2021-09-23 Pliva Hrvatska D.O.O. Solid state forms of sugammadex sodium
US11324692B2 (en) 2019-07-03 2022-05-10 Galenicum Health S.L.U. Method to prepare pharmaceutical compositions of suggamadex
US11097023B1 (en) 2020-07-02 2021-08-24 Par Pharmaceutical, Inc. Pre-filled syringe containing sugammadex
ES2949710T1 (es) 2020-07-03 2023-10-02 Galenicum Health S L U Método para preparar composiciones farmacéuticas
CN113387798B (zh) * 2021-05-08 2022-10-11 上海大学 用作逆转神经肌肉阻滞剂的水溶性柱[n]芳烃及其应用
CN113509486B (zh) * 2021-06-16 2022-07-19 南开沧州渤海新区绿色化工研究有限公司 Cca-cd共组装体在制备大分子毒素解毒药物中的应用
CN115057797B (zh) * 2022-02-24 2023-06-23 上海大学 一种水溶性联苯芳烃的合成及生物毒素解毒的应用
WO2025155981A1 (fr) * 2024-01-18 2025-07-24 University Of South Florida Cyclophanes à base de pyridinium et leurs procédés d'utilisation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929813A (en) 1973-12-26 1975-12-30 Interx Research Corp Novel pro-drug derivatives of pyridinium aldoxime type cholinesterase reactivators and process for preparing same
DK0447171T3 (da) 1990-03-15 1994-12-12 Tanabe Seiyaku Co Polysulfat af cyclodextrinderivat og fremgangsmåde til fremstilling deraf
US5180716A (en) 1990-08-01 1993-01-19 The Regents Of The University Of California Cyclodextrin complexes for neuraxial administration of drugs
US5840881A (en) 1992-11-27 1998-11-24 Takeda Chemical Industries, Ltd. Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility
US5767112A (en) 1994-10-21 1998-06-16 Poli Industria Chimica, S.P.A. Muscle relaxant pharmaceutical compositions
AU708107B2 (en) 1994-11-04 1999-07-29 Commonwealth Scientific And Industrial Research Organisation Method for treating animals
US5834446A (en) 1996-06-21 1998-11-10 Queen's University At Kingston Nerve process growth modulators
JP4249282B2 (ja) 1998-02-27 2009-04-02 日本食品化工株式会社 新規シクロデキストリン誘導体及びその製造方法

Also Published As

Publication number Publication date
US20100075938A1 (en) 2010-03-25
CN1241576C (zh) 2006-02-15
US7265099B1 (en) 2007-09-04
CA2380920C (fr) 2011-07-19
AR025103A1 (es) 2002-11-06
AU7508900A (en) 2001-03-13
EP1210090A2 (fr) 2002-06-05
BR0013126A (pt) 2002-04-23
CN1370073A (zh) 2002-09-18
JP2003507335A (ja) 2003-02-25
EP1210090B1 (fr) 2014-06-18
CA2380920A1 (fr) 2001-02-22
AU780416B2 (en) 2005-03-17
WO2001012202A2 (fr) 2001-02-22
JP4782334B2 (ja) 2011-09-28
WO2001012202A3 (fr) 2001-11-15
MXPA02001545A (es) 2002-08-30
US20070299035A1 (en) 2007-12-27

Similar Documents

Publication Publication Date Title
IL147887A0 (en) Use of chemical chelators as reversal agents for drug-induced neuromuscular block
PL356097A1 (en) 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
HUP0102901A3 (en) Use of n-formyl hydroxylamines as antibacterial agents
HUP0202248A3 (en) Compounds useful as anti-inflammatory agents
PL369337A1 (en) Spiro-hydantoin compounds useful as anti-inflammatory agents
IL154292A0 (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell profiliferation
EE200100647A (et) Ühendite uus kasutamine antibakteriaalsete ainetena
GB9914977D0 (en) Chemical compounds
GB9907658D0 (en) Chemical compounds
GB9902461D0 (en) Chemical compounds
GB9909409D0 (en) Chemical compounds
GB9914440D0 (en) Chemical compounds
PL349137A1 (en) Use of cholesterol-lowering agent
HUP0204208A3 (en) Antipruritic agents for external use
GB9910104D0 (en) Chemical compounds
GB0029903D0 (en) Use of anti-muscarinic agents
GB9923882D0 (en) Chemical composition
GB9900078D0 (en) Chemical compounds
AU2002244720A1 (en) 2-alkylated-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
GB9910394D0 (en) Chemical compounds
GB9914026D0 (en) Chemical compounds
GB9914024D0 (en) Chemical compounds
GB9914015D0 (en) Chemical compounds
GB9914022D0 (en) Chemical compounds
GB9810855D0 (en) Use of compounds

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed